
Hi A***r,
I’m J***e from StrategyBrain. I came across your profile and was impressed by your track record leading corporate strategy and business development at N***s and F***n K***e,especially your work on strategic planning, high-value partnerships, and capital raising.
We’re currently partnering with C***a B***a to recruit a Vice President, China Corporate Strategy & Business Development. Given your experience in portfolio prioritization, deal negotiations, and cross-functional leadership, I think this could be a great fit. Would you be open to a brief chat to learn more about the opportunity?
Looking forward to your thoughts.
Best regards,
J***e
HR Recruiter, StrategyBrain
Hi J***e, thanks for reaching out. The VP China Corporate Strategy & BD role at C***a B***a sounds intriguing,my background in portfolio prioritization and high-value deal negotiations at N***s and F***n K***e could be a great fit. I’d love to chat briefly,what’s your availability?


Hi A***r,
Great to hear from you,thanks for your interest. I’m available for a 30-minute call next week. Would any of these slots work for you (all CST)?
• Tuesday 4:00,4:30 PM
• Wednesday 10:00,10:30 AM
• Thursday 2:30,3:00 PM
Here’s a quick overview of the VP, China Corporate Strategy & BD role at C***a B***a:
1. Company & Impact
, C***a is a fast-growing global biotech leader (5,000+ employees) focused on cell and gene therapies.
, This role sits on the China Leadership Team, directly shaping regional strategy and forging high-impact partnerships.
2. Core Responsibilities
, Lead 1/3/5-year corporate planning and portfolio prioritization (leveraging your N***s/F***n K***e experience).
, Identify, evaluate and negotiate top-tier licensing, JV and M&A deals with global biotech innovators.
, Oversee cross-functional teams (medical, commercial, regulatory) on new indication planning and launch readiness.
, Manage shareholder relations and support capital-raising initiatives through strategic communications and investment pitches.
, Apply advanced financial modeling and risk-adjusted DCF to inform business cases and investment decisions.
3. Why This Role Fits You
, You’ve driven 52% QoQ sales growth and secured major capital injections,exactly the impact we’re looking for.
, Your track record in deal negotiations (A***T, A***e, Y***a) aligns perfectly with our partnership ambitions.
, You’ll have a direct line to the executive team and the autonomy to shape C***a’s China roadmap.
4. Growth & Benefits
, Clear path toward broader Asia-Pacific or global leadership.
, Competitive salary, performance bonuses and equity package.
, Robust support from an experienced cross-functional team and ample resources to execute bold initiatives.
Please let me know which time works best or if you need other options. Happy to dive deeper into any aspect of the role or C***a’s roadmap that interests you.
Looking forward to our conversation!
Best,
J***e
HR Recruiter, StrategyBrain
Wednesday 10:00,10:30 AM CST works for me. Could you also share the expected salary range and bonus structure before our chat?


Hi A***r,
Great,I’ve booked Wednesday, 10:00,10:30 AM CST for our call.
As for compensation, the VP, China Corporate Strategy & BD role at C***a typically offers:
• Base salary in the range of RMB 2.0,2.5 million per year
• Annual performance bonus target of ~30,40% of base
• Competitive equity grant as part of the long-term incentive package
The exact numbers will be calibrated to your background and overall fit, and we can go through the full breakdown on our call. Looking forward to chatting Wednesday!
Best,
J***e
HR Recruiter, StrategyBrain
Thanks J***e,that range sounds reasonable given my track record leading strategic growth and capital raises at N***s and F***n K***e. Could you share a bit more on the equity grant size/vesting schedule and how performance metrics tie into the bonus? Looking forward to our chat Wednesday.


Hi A***r,
Happy to dive into the details ahead of our call:
• Equity grant:
, Typical VP award is in the range of 0.2,0.3% of fully diluted shares (roughly 1,1.5× your base salary)
, Vesting over four years with a one-year cliff (25% at year 1, then quarterly thereafter)
• Performance bonus (30,40% target):
, Measured against a balanced scorecard that includes:
· Achievement of China strategic-plan milestones (1/3/5 year goals)
· Completion and integration of high-value partnerships, JVs or M&A deals
· Progress on fundraising or capital-raise initiatives
· Commercial metrics such as China sales and margin growth
We’ll go through the specifics and answer any follow-ups on Wednesday at 10:00 AM CST. Looking forward to our conversation!
Best regards,
J***e
HR Recruiter, StrategyBrain
Thanks, J***e,this really helps. Quick follow-ups: are these equity awards RSUs or options, and is there any change-of-control acceleration? Also, how are the bonus scorecard metrics typically weighted across those four categories?


Hi A***r,
Glad these details help. Here’s some additional color:
1. Equity structure
- Awards are granted as RSUs (not options).
- Vesting over four years with a one-year cliff (25% at Year 1, then quarterly thereafter).
- We have a standard double-trigger change-of-control provision: in the event of an acquisition and subsequent termination within 12 months, your unvested RSUs fully accelerate.
2. Bonus scorecard weighting (target bonus = 30,40% of base)
- ~30% tied to China strategic-plan milestones (1/3/5-year goals)
- ~30% tied to completion and integration of high-value partnerships, JVs or M&A deals
- ~20% tied to fundraising and capital-raise initiatives
- ~20% tied to commercial performance (China sales growth, margin improvement)
We can fine-tune these weightings based on your priorities when we speak Wednesday at 10:00 AM CST. Let me know if there’s anything else you’d like covered beforehand,I’m happy to help.
Looking forward to our call!
Best,
J***e
HR Recruiter, StrategyBrain
Thanks J***e,this is really helpful. The 30/30/20/20 bonus split makes sense, though I’d lean toward a bit more weight on high-value deals/JVs given my track record. Also curious on flexibility around the 0.2,0.3% RSU range; happy to dive into that on Wednesday.


Thanks, A***r. Given your strong track record driving high-value JVs at F***n K***e and N***s, we can certainly bump more of the bonus weighting toward partnership/M&A milestones. On the RSUs, I’m happy to explore flexibility around the top end of the 0.2,0.3% range based on deal impact. We’ll plan to cover both in detail on Wednesday at 10:00 AM CST. If there’s anything else you’d like on the agenda, just let me know. Looking forward to our conversation!
Best,
J***e